DE69806036D1 - 3-oxo-2(h)-1,2,4-triazinderivate als 5ht1a rezeptor liganden - Google Patents
3-oxo-2(h)-1,2,4-triazinderivate als 5ht1a rezeptor ligandenInfo
- Publication number
- DE69806036D1 DE69806036D1 DE69806036T DE69806036T DE69806036D1 DE 69806036 D1 DE69806036 D1 DE 69806036D1 DE 69806036 T DE69806036 T DE 69806036T DE 69806036 T DE69806036 T DE 69806036T DE 69806036 D1 DE69806036 D1 DE 69806036D1
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- optionally substituted
- group
- hydrogen
- trifluoromethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9712955A FR2769912B1 (fr) | 1997-10-16 | 1997-10-16 | Nouveaux derives de la 3-oxo- (2h)-1,2,4 triazine leur preparation et leur application en therapeutique humaine |
PCT/FR1998/002205 WO1999020622A1 (fr) | 1997-10-16 | 1998-10-14 | Derives de la 3-oxo-2(h)-1,2,4-triazine en tant que ligands des recepteurs 5ht1a |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69806036D1 true DE69806036D1 (de) | 2002-07-18 |
DE69806036T2 DE69806036T2 (de) | 2003-01-30 |
Family
ID=9512298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69806036T Expired - Lifetime DE69806036T2 (de) | 1997-10-16 | 1998-10-14 | 3-oxo-2(h)-1,2,4-triazinderivate als 5ht1a rezeptor liganden |
Country Status (14)
Country | Link |
---|---|
US (1) | US6303603B1 (de) |
EP (1) | EP1023287B1 (de) |
JP (1) | JP4413424B2 (de) |
CN (1) | CN1128147C (de) |
AT (1) | ATE219076T1 (de) |
AU (1) | AU761653B2 (de) |
BR (1) | BR9812928B1 (de) |
CA (1) | CA2306428C (de) |
DE (1) | DE69806036T2 (de) |
DK (1) | DK1023287T3 (de) |
ES (1) | ES2177063T3 (de) |
FR (1) | FR2769912B1 (de) |
PT (1) | PT1023287E (de) |
WO (1) | WO1999020622A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2405758A1 (en) * | 2000-05-12 | 2001-11-15 | Solvay Pharmaceuticals B.V. | Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders |
EP1558589A4 (de) * | 2002-10-11 | 2008-01-09 | Cytokinetics Inc | Verbindungen, zusammensetzungen und verfahren |
US7160888B2 (en) | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
EP1856126A2 (de) * | 2005-02-17 | 2007-11-21 | Wyeth a Corporation of the State of Delaware | Cycloalkyl-anelliertes indol, benzothiophen, benzofuran und inden-derivate |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2707294B1 (fr) * | 1993-07-06 | 1995-09-29 | Pf Medicament | Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine. |
DE4442229A1 (de) * | 1994-11-28 | 1996-05-30 | Hoechst Schering Agrevo Gmbh | Alkylidenhydrazinophenylsulfonylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
FR2727682A1 (fr) * | 1994-12-02 | 1996-06-07 | Pf Medicament | Nouveaux derives de 3,5-dioxo-(2h,4h)-1,2,4-triazines, leur preparation et leur application a titre de medicament |
-
1997
- 1997-10-16 FR FR9712955A patent/FR2769912B1/fr not_active Expired - Fee Related
-
1998
- 1998-10-14 DE DE69806036T patent/DE69806036T2/de not_active Expired - Lifetime
- 1998-10-14 WO PCT/FR1998/002205 patent/WO1999020622A1/fr active IP Right Grant
- 1998-10-14 EP EP98949061A patent/EP1023287B1/de not_active Expired - Lifetime
- 1998-10-14 AT AT98949061T patent/ATE219076T1/de active
- 1998-10-14 BR BRPI9812928-7A patent/BR9812928B1/pt not_active IP Right Cessation
- 1998-10-14 ES ES98949061T patent/ES2177063T3/es not_active Expired - Lifetime
- 1998-10-14 US US09/529,728 patent/US6303603B1/en not_active Expired - Lifetime
- 1998-10-14 DK DK98949061T patent/DK1023287T3/da active
- 1998-10-14 CA CA002306428A patent/CA2306428C/fr not_active Expired - Fee Related
- 1998-10-14 CN CN98811028A patent/CN1128147C/zh not_active Expired - Fee Related
- 1998-10-14 AU AU95457/98A patent/AU761653B2/en not_active Ceased
- 1998-10-14 JP JP2000516964A patent/JP4413424B2/ja not_active Expired - Fee Related
- 1998-10-14 PT PT98949061T patent/PT1023287E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
CA2306428A1 (fr) | 1999-04-29 |
DK1023287T3 (da) | 2002-10-14 |
AU761653B2 (en) | 2003-06-05 |
EP1023287B1 (de) | 2002-06-12 |
DE69806036T2 (de) | 2003-01-30 |
CN1128147C (zh) | 2003-11-19 |
ATE219076T1 (de) | 2002-06-15 |
CN1278815A (zh) | 2001-01-03 |
FR2769912B1 (fr) | 2000-03-10 |
JP2001520226A (ja) | 2001-10-30 |
FR2769912A1 (fr) | 1999-04-23 |
AU9545798A (en) | 1999-05-10 |
ES2177063T3 (es) | 2002-12-01 |
WO1999020622A1 (fr) | 1999-04-29 |
EP1023287A1 (de) | 2000-08-02 |
PT1023287E (pt) | 2002-11-29 |
US6303603B1 (en) | 2001-10-16 |
BR9812928A (pt) | 2000-08-08 |
BR9812928B1 (pt) | 2013-03-19 |
CA2306428C (fr) | 2010-01-12 |
JP4413424B2 (ja) | 2010-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU1900A (sh) | Derivati ariloksiarilsulfonilamino hidroksaminske kiseline | |
CO4970780A1 (es) | Nuevos compuestos heterociclicos de piridazina | |
DK1022272T3 (da) | Substituerede, fusionerede, heterocykliske forbindelser | |
ATE169008T1 (de) | 3,5-dioxo-(2h,4h)-1,2,4-triazinderivate ihre herstellung und verwendung als medikament | |
HUP0202799A2 (hu) | Herbicid hatású izoxazolinszármazékok és azt tartalmazó készítmény | |
DE69332792D1 (de) | 4,1-Benzoxazepinderivate als Squalen-Synthetase Inhibitoren und ihre Verwendung zur Behandlung von Hypercholesterämie und als Fungizide | |
DE69918695D1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
ES395714A1 (es) | Procedimiento para la obtencion de derivados de piridoqui- nolina. | |
DK0947504T3 (da) | 16-en-vitamin D-derivater | |
MX2010010471A (es) | Derivado de tetrahidroisoquinolina novedoso. | |
DE69806036D1 (de) | 3-oxo-2(h)-1,2,4-triazinderivate als 5ht1a rezeptor liganden | |
FR2702477B1 (fr) | Dérivés de benzoxazine, leur préparation et leur application en thérapeutique. | |
WO2000024717A3 (en) | Isoquinoline derivatives | |
NO955328L (no) | Pyridazinon-derivater | |
BG104309A (en) | 8-azabicyclo[3,2,1]octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors | |
DE69915471D1 (de) | Analoga von distamycin-zimtsäurederivaten, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel | |
TW350843B (en) | 2-(4-pyrazolyloxy-pyrimidin-5-yl) acetic acid derivatives | |
NO982549L (no) | 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav | |
DK193090D0 (da) | Imidazolyl- og pyridylderivater af phenylsubstituerede 1,4-dihydropyridiner og fremgangsmaade til fremstilling deraf | |
DE60312511D1 (de) | Oxophenylcyclohexylpropanolaminderivate, deren herstellung und verwendung in therapeutika | |
TW351717B (en) | Pyenyl-substituted cyclic ketoenols | |
ATE148462T1 (de) | Isoxazole derivate als lichtschutzmittel | |
HUP0402229A2 (hu) | TNF-aktivitású tetrahidropiridil-alkil-heterociklusos vegyületek és ezeket tartalmazó gyógyszerkészítmények | |
YU28701A (sh) | N-(2-(heteroaril)etil)-3-fenilpiperidini, n-(2-(heteroaril) etil)-4-fenilpiperidin i srodna jedinjenja sa supstituentom u položaju 4 piperidinskog prstena |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |